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ABSTRACT
Exosomes are extracellular, cell signaling microvesicles that contain unique
genomic and proteomic signatures reflective of the host cell’s pathophysiological
conditions. In recent years, the study of exosomes has increased tremendously because
many have been recognized as molecular biomarkers with the potential to advance
methods of disease diagnostics and therapeutics as well as contribute to physiological
analyses of multiple organism types. With the promising potential that exosomes offer to
the field of molecular biology, it is vital to establish an efficient and consistently reliable
mechanism of exosome isolation from biological samples. Many isolation techniques
currently available typically yield exosome samples with numerous contaminants,
making them low in purity for exosome content. Our lab has developed a novel
technology for solid-phase exosome purification directly from biological samples. This
study utilizes SDS-PAGE and fluorescent imaging analysis to assess the specificity of the
ExoSense microprobe-based exosome isolation technology. The proteomic profile
generated from the SDS-PAGE shows fewer bands with a cleaner background for the
microprobe-based sample compared to the traditional polymer precipitated exosome
proteins, suggesting an exosome population higher in purity from the microprobes than
what the polymer reagent provides. Fluorescent imaging resulted in distinct differences
between the control and exosome-specific groups, indicating an exosome-specific
population captured using the probes. Results from this study can be used collectively to
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validate the specificity of the novel ExoSense exosome capture technology. Future
studies can be applied for optimizing the technology for commercial applications.
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CHAPTER 1
INTRODUCTION

1.1

Objective

The goal of this study is to validate the specificity of a microprobe-based method
for direct immunocapture of a CD63-positive subpopulation of exosomes via SDS-PAGE
and fluorescent imaging. We hypothesize that the microprobes are capable of selectively
isolating a subpopulation of exosomes carrying specific surface protein markers. CD63 is
a member of the tetraspanin family that is one of the most abundant proteins found on the
surface of exosomes and thereby is expected to provide selectivity to the isolation
procedure (Pols and Klumperman, 2009). Biotinylated stainless-steel microprobes (130
μm in diameter, 30 mm in length) will be functionalized with an anti-CD63 antibody
conjugated to streptavidin that selectively binds to this protein marker expressed by the
exosomes. The probes will be used for selective capture of extracellular vesicles directly
from astrocyte-conditioned cell media. Our preliminary results indicate that the average
loading capacity is 2.8×106 exosomes per probe. We aim to confirm our hypothesis with
two experimental objectives: 1) analyze the proteomic content of captured vesicles using
SDS-PAGE analysis, and 2) characterize the captured vesicles on the surface of the
probes using fluorescent imaging analysis.
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1.2

Rationale

Exosomes are extracellular vesicles that are indicative of the pathophysiological
conditions of the host cell and can modify the physiological response by reprograming
the recipient cell (Valadi et al., 2007). While exosomes are released under normal
physiological conditions, their number is increased upon neurodegeneration or neoplastic
transformation and are emerging as crucial biomarkers for disease diagnostics (Soung et
al., 2017). Astrocytes regulate brain function by maintaining ion, metabolic, and
neurochemical homeostasis. The nature of astrocyte-to-neuron communication is
mediated by direct cell-to-cell contact as well as by a complex array of exosomes that
carry a diverse pool of non-coding microRNAs capable of reprogramming protein
expression in recipient cells. Therefore, astrocyte-derived exosomes from these cells give
insight into the physiological status of the nervous system (Men et al., 2019). Selective
isolation and genetic analysis of exosome subpopulations that express the same surface
protein markers is crucial in studies of the central nervous system (Kowal et al., 2016).
1.3

Significance

The proposed exosome purification technology is based on a microprobe method
for site-specific exosome purification that is non-destructive to the biological specimen.
Selective isolation of exosome subpopulations that express the same surface protein
markers is crucial in proteomics and genomics studies of extracellular vesicles (Kowal et
al., 2016). Because of their distinct surface proteins and vesicular content, exosomes have
the potential to have a significant impact on molecular biology studies. For example,
CD63 positive exosomes are present at a higher level in malignant cells compared to
normal cells (Logazzi et al., 2009). However, the potential use of exosomes in a clinical
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or research setting is fully dependent on the successful isolation of exosomes from
biological samples. The developed ExoSense microprobe-based technology is expected to
have an important impact in the field of extracellular vesicle research as the
immunocapture approach will enable selective purification of exosomes expressing the
same surface marker and enable integration with standard systems for genomic and
proteomic downstream analysis.

CHAPTER 2
BACKGROUND
2.1

Exosome Structure and Biogenesis

Exosomes are small extracellular cell signaling molecules that have been
increasingly studied in the last decade as their structural features and physiology provide
evidence of these vesicles playing a large role in various cell signaling and homeostatic
regulatory processes (Mathieu et al., 2019). The earliest studies of exosomes focused on
characterizing the inner structural components which differentiate exosomes from other
microvesicles. Valadi et al. performed an extensive genetic analysis on exosomes and
compared the results with a genetic analysis of the host cells because they hypothesized
that exosomes contain unique messenger RNA (mRNA) and microRNAs (miRNA)
which are involved in post-translational alterations in the recipient cell. These studies
confirmed that exosomes contain specific miRNAs and mRNAs which can alter the
biological activity of the recipient cell post-translationally. The results of this study
provided evidence of exosomes being potentially critical regulators of cellular
homeostasis (Valadi et al., 2007).
Exosomes are extracellular vesicles that are endosomal in origin and actively
mediate communication between cells. The intracellular pathway of exosome biogenesis
begins with the formation of endosomes from an enfolding cellular membrane that
contains varying proteins and other signaling molecules. This early endosome is
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processed in a membranous system referred to as multivesicular bodies (MVB) (Hessvik
& Llorente 2018). Within the MVB compartments, the cell-signaling molecules are
sorted into new vesicles for subsequent release from the cell. New molecules are also
oriented into these spaces depending on the directed needs of the signaling molecules.
This stage of exosomal development is orchestrated by four multiprotein complexes
referred to as the endosomal sorting complexes required for the transport (ESCRT)
pathway (Figure 2.1). There is also a pathway that directs the formation of exosomes
independently from the ESCRT proteins. However, this pathway is less well defined (Ha
et al., 2016).

6

Figure 2.1: Exosome vs. microvesicle biogenesis pathway. Overview of exosome
formation via endocytosis, development into multivesicular bodies, the orientation of new
molecules mediated by ESCRT, and late multivesicular body formation. Microvesicles
form by budding orchestrated by lysosomal processing of late MVBs. Exosomes are
excreted via exocytosis of late MVBs. Figure adapted from Ha et. al, 2016 Figure 2.

2.2

Exosomes in Biomedical Research and Diagnostics

Exosomes are signaling vesicles that have recently emerged as biomarkers and a
drug delivery platform for the advancement of disease diagnostics, monitoring, and
therapeutics. Exosomes reflect the pathophysiological conditions of the host cell and can
modify the physiological response by reprogramming the recipient cell (Mathieu et al.
2019). Exosomes contain unique protein markers on their surface as well as proteins,
miRNAs, and mRNA of their cell of origin that allow them to be used as disease
biomarkers (Valadi et al. 2007). Exosomes mediate immune responses (Anel et al. 2019),
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cancer progression (Soung et al. 2017), and central-nervous system-related diseases (Liu
et al. 2019).
In cancer diagnostics, several specific exosomal biomarkers have been identified
through a comprehensive analysis of cancer cell-derived exosomes. For example, CD24
and EpCAM are two exosomal proteins associated with both breast and ovarian cancer,
while EGFR seems to be unique to glioblastomas (Soung et al., 2017). In Parkinson’s
studies, exosomes were found to indirectly upregulate the expression of Syntenin, which
now serves as a specific biomarker for tissue changes in the onset of neurodegenerative
disease (Tomlinson et al., 2015). Both of these studies identify specific exosomal
properties as unique biomarkers in complex diseases, vastly supporting the potential of
exosomes to contribute advancements in biomedical disease diagnostics and therapeutics.
Exosomal membranes are enriched in tetraspanins (CD63, CD9, and CD81) that
are used as biomarkers for disease diagnostics and prediction of therapeutic response
(Andreu and Yanez-Mo 2014). Isolation and genetic analysis of antigen-specific vesicles
from the total exosome population are crucial for understanding the state of degenerating
tissues that are otherwise inaccessible in the central nervous system (Kowal et al. 2016).
Astrocyte-neuron communication is the key regulator of overall brain function, so
exosomes from these cells serve as important indicators of the progression of
neurological diseases in brain tissues (Men et al. 2019). There is no current method that
noninvasively isolates exosome subpopulations, which all share membrane-specific
tetraspanin markers, from other vesicles. Isolation of a pure exosomal population from
biological tissues is an important prerequisite for the development of extracellular
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vesicle-based therapies and the discovery of disease-specific biomarkers (Kowal et al.
2016).
2.3

Overview of Exosome Purification Techniques

The current methods of exosome isolation all have limitations that prevent the
application of exosomes in a clinical or laboratory setting, and therefore prevent the study
of exosomes from reaching their full potential. Multiple technologies that improve
exosomal isolation have been developed, and the process has rapidly evolved in recent
years. Methods of exosome isolation currently include ultracentrifugation and filtration,
size-exclusion techniques, polymer precipitation, immunoaffinity, and microfluidics
(Doyle and Wang 2019). Most ultracentrifugation methods are coupled with filtration to
increase total exosomal yield. This method can vary slightly from protocol to protocol but
includes a series of ultracentrifugation steps at high speeds with long assay times.
Ultracentrifugation generally has a low exosomal yield (< 5%), meaning that less than
5% of the total sample volume recovered in the final product consists of microvesicles
and high rates of contamination due to tearing of the membranes and clumping (Livshits
et al. 2015). A size-exclusion approach yields a purer exosome subpopulation compared
to ultracentrifugation because microvesicles are very small in size and the solid phase of
the chromatography column removes cell lysate or other sources of contamination
(Gheinani et al. 2018). Although size-exclusion has a simpler protocol and involves more
readily available equipment, it still has a low total yield (< 8%) and provides a population
of exosomes that express a variety of surface markers (Doyle and Wang 2019).
Polymer precipitation is the most common approach to exosome isolation. It
requires little equipment, encompasses a simple protocol, and provides a relatively high
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total product yield (> 25%). This method, however, can only process a very small sample
volume, has a long assay time (8 h or more), and carries the risk of compromising the
structural integrity of the microvesicles isolated (Konoshenko et al. 2018).
Immunoaffinity techniques largely involve the use of antibody-coated beads which are
target-specific and can be used in almost any biological media. This method is highly
specific and has a high total yield and purity at the time of capture (> 99%). However, the
reagents required to remove the exosomes from the beads for analysis destroy most of the
microvesicle product, rendering them inadequate for scientific analysis (Doyle and Wang
2019).
Microfluidics strategies attempt to combine lab-on-a-chip technologies with
common isolation methods including size-exclusion (Lee et al. 2015) or immunoaffinity
(Zarovni et al. 2015) for exosome isolation. The main goals of these techniques are
target-specific capture while reducing potential contamination from excess cell debris or
buffers and increasing the overall total product yield. These microfluid methods,
however, have no standardized protocol and yield a variety of experimental results (Yu et
al. 2018). The advantages and disadvantages of current exosome capture methods can be
summarized by comparing the most common exosomal isolation techniques (Table 2.1).
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Table 2.1: Comparison of current exosome isolation methods. Product yield is the
percent of total sample volume recovered in the final product which consists of
microvesicles. The concentration is indicated by the number of particles per mL (ppm)
that are measured in the final product, determined by nanoparticle tracking analysis.
Sample volume is how much volume can be processed by the assay. Primary advantages
and disadvantages are listed.
Method

Product Yield
Concentration

Ultracentrifugation

Polymer

Immunoaffinity

+ Filtration

Precipitation

Beads

5-25%

> 25%

99%

42-97%

N/A

High; (amount unspecified)

1.1 x 10

9

1.8 x 10

11

Microfluidics

(ppm)
> 100 mL

͌ 100 µL

< 1mL

20-50 µL

Primary

Processes large

Simple

Target specific,

Highest recorded product

Advantage

sample volume

protocol

yielding high

yield and purity level

Sample
Volume

purity
Primary

Lowest recorded

Low purity

Unable to

Unstandardized protocol,

Disadvantage

product yield and

level,

characterize

leading to varied

purity level

damaged

recovered

experimental results

vesicles

vesicles (from
damage)

2.4

ExoSense Solid-Phase Purification of Extracellular Vesicles

The exosome purification technology that we are developing is based on a
microprobe method for noninvasive and site-specific exosome purification and genetic
analysis. Stainless-steel exosome capture pins (130 µm×30 mm) are functionalized with
an anti-CD63 antibody that selectively binds to the corresponding tetraspanin (Figure
2.2). A microprobe-based approach to exosome isolation eliminates the need for large,
expensive equipment in the protocol and creates a platform that can elegantly interface
with downstream genomics and proteomics technologies for point-of-care diagnostics. .
Microneedles are non-destructive to the sample and are therefore a preferred method of
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laboratory testing in a medical setting. This developed approach could reduce the current
lengthy, multistep exosomes isolation procedures to a single step.
To produce site-specific exosome capture directly from biological samples, a
stainless-steel microprobe was functionalized with an antibody specific to a tetraspanin
(CD63) that is expressed on the surface of the vesicles. The first layer coating the needles
consists of alternating oppositely charged polyelectrolytes via layer-by-layer assembly.
Five bilayers of positively charged polyethylene and negatively charged polyacrylic acid
were adhered first to produce a stable precursor layer for the covalent linkage of biotin
followed by the immobilization of streptavidin-conjugated anti-CD63 antibodies.
Carbodiimide cross-linker chemistry (EDC) is used to form the chemical bond between
the amine group of the biotin and the carboxyl group of the polyacrylic acid (Lvov et al.
1995). Streptavidin-conjugated anti-CD63 forms a covalent bond with the biotin,
providing stable immobilization of the anti-CD63 antibody on the surface of the probe.
This integration of this immobilization technique on the surface of the microprobe
enables the development of a non-invasive tool for the immunoisolation of exosomes
directly from biological sources without the requirement of an intermediate, exosomes
pre-enrichment step.
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Figure 2.2: Schematic of the anti-CD63 functionalized microprobe as a sensitive
bioanalysis platform for purification of exosomes.
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2.5
2.5.1

Proteomic Analysis of Extracellular Vesicles

SDS-PAGE
Electrophoresis is a technique that separates proteins based on their size in an

electric field gradient. A mixture of protein samples moves from the positive electrode to
the negative one. Since proteins with lower molecular weight migrate faster, the mixture
is separated based on the size of the peptides. Proteins have a variable charge that is
determined by the type and sequence of the amino acids. To impart an overall negative
charge, the proteins are coated with sodium dodecyl sulfate (SDS) before running the gel
(Manns, 2011).
SDS-PAGE is a useful tool for exosome studies because the protein profile of
collected samples can be visually compared. In one study, SDS-PAGE was used to
determine if protein bands were thicker in exosomes isolated from plasma versus serumextracted exosome samples. From these SDS-PAGE results, the authors were able to
suggest which of the two biological sources of exosomes may yield a stronger proteomic
signal (Grunt et al., 2020). Another study uses multiple SDS-PAGE analyses as
supporting evidence that exosomes collected from the same biological source at different
time points contain an unpredictable number of proteins (Burkova et al., 2019).
Our study utilizes SDS-PAGE analysis to assess the differences and similarities in
the protein bands profile among total cellular protein samples, exosomes purified via
traditional polymer precipitation, and exosomes purified via the ExoSense capture pin
technology. SDS-PAGE is useful to our study because we can compare how the protein
content of both exosome samples compares with the protein purified from the total cell
lysate. Applying SDS-PAGE to this study will help us assess the specificity of the
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ExoSense capture technique and to predict the identity of the protein bands within the
gel.

2.5.2

Western Blot
Western Blot is a laboratory technique that is commonly used for the detection of

a specific protein in a variety of biological sample types. It is both a size exclusion and an
antigen-specific method of protein detection that allows for accurate quantification of the
protein of interest. The method is also used for the detections of posttranslational
modifications such as phosphorylations and glycosylation in biological specimens
(Kurien & Scofield, 2006).
Because Western Blot enables highly specific protein detection and
quantification, it is also used to assess both the proteomic content of exosomes and to
validate the efficiency of the extraction method. For instance, one study used Western
blot to confirm the presence of specific protein markers that distinguish between vesicle
subtypes in a biological sample (Kowal et al., 2016). Another study utilizes Western blot
to characterize TNF-α-like exosomes in the immune system as biomarkers for arthritis
(Zhang et al., 2006). In these studies, however, Western blot is used in addition to another
method of confirmation such as mass spectrometry for validating exosome protein
markers because other vesicle subtypes are often present and may interfere with the
antibody signal in the isolated exosome samples (Dash et al., 2021). Applying Western
blot to exosome characterization studies is a useful tool for validation of the exosomal
protein markers amongst other vesicle subtypes (Kowal et al., 2016).
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2.6

Fluorescent Imaging Technique

Fluorescent immunodetection is a molecular biology technique that can be used to
identify and characterize distinct features on the surface of cells or other biological
samples using a fluorophore-conjugated antibody. At the core of this approach is a
molecule that absorbs light or other electromagnetic radiation and emits light in a longer
wavelength frequency (Hildonen et al., 2016).
Fluorescent imaging can be used to assess the efficiency of the ExoSense probe
enrichment via detection with tetraspanin-specific primary antibodies followed by a
fluorophore-conjugated secondary IgG antibody. The presence of exosome-specific
surface markers will be assessed using primary antibodies against native epitopes of CD9
and CD81 therefore visually characterizing the tetraspanin surface proteins of the
captured exosomes. The fluorescent approach for characterizing and imaging exosomes
can be performed on the surface of the microprobes without removing the exosomes from
the probe or lysis of the vesicles (Figure 2.3).
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Figure 2.3: Schematic of exosome isolation and fluorescence imaging. Exosomes will
adhere to the surface of the microprobes through antibody-specific interactions of antiCD63+ (biotinylated to needle surface) and CD63+ (exosome surface protein). Exosome
morphology can be characterized with imaging of the CD9, anti-rabbit fluorophore
antibody system.

17

CHAPTER 3
METHODS
3.1

Layer-by-layer Functionalization

At the core of the ExoSense solid-phase exosome purification technology were
stainless steel probes (130 µm×30 mm) functionalized with a layer-by-layer (LbL)
assembly which consists of 6 bilayers of polyelectrolytes with opposite charges. Before
LbL immobilization, the probes were polished with sandpaper. To remove organic
materials, the probes were ultrasonically washed in acetone for 5 minutes, ultrapure water
for 5 minutes, in hexane for 15 minutes, and then in ultrapure water heated to 50 °C for
15 minutes. The probes were then ultrasonically washed in acetone again for 5 minutes
and dipped in acetone heated to 50 °C for 15 minutes. To create a uniform hydroxyl
group coverage, the probes were etched using sulfochromic acid (prepared by dissolving
6 g of K2Cr2O7 in 100 mL of H2SO4) at 60 °C for 10 minutes and stored under a vacuum
until LbL assembly.
The etching step lays a solid foundation on the probes for the polyelectrolyte
immobilization by coating them with charged OH molecules that will strongly adhere the
first polyelectrolyte layer to the surface of the probes. The first polyelectrolyte layer
consists of negatively charged poly(ethylenimine) (PEI) (MP Biomedicals, Cat. #
195444) and was prepared by dissolving 6 mL of PEI in 94 mL of D.I. water along with
25 µL of 0.5 M NaCl to obtain a 3 mg/mL PEI solution with a pH of 5. HCl and NaOH
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were used to adjust the pH to the required value for the polyelectrolyte solutions. The
second polyelectrolyte layer consists of positively charged poly(sodium 4styrenesulfonate) (PSS) (Sigma-Aldrich, Cat. # 243051) and was prepared by dissolving
60 mg of PSS in 20 mL of D.I. water along with 25 µL of 0.5 M NaCl to obtain a 3
mg/mL PSS solution with a pH of 8. All remaining positively charged layers were
orchestrated using polyacrylic acid (PAA) (Sigma-Aldrich, Cat. # 523925), and PAA was
prepared by dissolving 6 mL of PAA in 63.6 mL of D.I. water and 25 µL of 0.5 M NaCl
to obtain a 3 mg/mL PAA solution with a pH of 8.
The layer-by-layer assembly was immobilized with alternating charged
polyelectrolyte layers. The probes were dipped in each solution for their allotted time,
placed in D.I water for rinsing, and allowed to air dry before adding the next layer: PEI –
45 mins, PSS – 15 mins, PEI – 15 mins, PAA – 15 mins, PEI – 15 mins, PAA –
Overnight (16 hours), PEI – 1 hour, PAA – 30 mins, PEI – 30 mins, PAA – 30 mins, PEI
– 2 hours, PAA – 30 mins. Following the layer-by-layer assembly, all probes were
immobilized with a biotin-EDC linker complex to provide a stable adherence of the
primary antibody for exosome capture. The biotin (ThermoFisher, Cat. # 21346) was
prepared at 50 mM and the EDC (ThermoFisher, Cat. # 22980) solution was prepared at
100 mM. The biotin and EDC solutions were then mixed 1:1 to achieve a final
concentrartion of 25 mM solution. The probes were submerged in the biotin-EDC
solution for 2 hours at room temperature and then incubated in the streptavidinconjugated anti-CD63 primary antibody (Abcore, Cat. # AC12-0278-22) at a 1:1000
dilution at room temperature for 1 hour.
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3.2

Exosome Purification

Exosomes were isolated from conditioned astrocytes media (ACM) using a total
exosome isolation reagent (Thermo Fisher Scientific, Cat. # 4478359). This reagent
forms a mesh around the exosomes that further pelleted using centrifugation from the rest
of the cellular complement. This represents a control group of exosomes isolated using
the traditional method that will serve as a basis for comparison with the ExoSenseisolated exosomes. Human astrocytes (ScienCell™ Cat. #1800) were cultured until 90%
confluent according to the standard protocol using primary cell culture medium (TFS,
Cat. #A1261301). The astrocytes released exosomes for 72 hours into the cell media
before collection. The cell media was collected and centrifuged at 2000 G for 30 mins for
pre-clearing of cell debris. The ACM was then transferred to a new tube and stored at -80
°C until further use. The ACM was allowed to thaw at room temperature and mixed with
the isolation reagent at a ratio of 2:1 according to the protocol. The sample was vortexed
and incubated at 4 °C for 24 hours. The exosomes were pelleted using centrifugation at
10,000 G for 1 hour at 4 °C. The supernatant was discarded, and the pellet resuspended in
RIPA lysis buffer with protease inhibitors. A 7x protease stock solution was prepared by
dissolving a cOmplete™ protease inhibitor cocktail tablet (Roche, Cat. # 04693124001)in
1.5 mL of D.I water. RIPA was prepared by mixing the protease inhibitor cocktail in a
ratio of 1:7 according to the vendor recommendations.
The ExoSense protein lysate samples were prepared using 85 probes following
the procedure described above. The exosomes capture pins were incubated for 16 hours at
4 °C in ACM. The exosomes were then lysed using the same RIPA solution as for the
traditional sample, and the corresponding protein and RNA cargo were purified. A BCA
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assay (Thermo Fisher Scientific, Cat. # 23225) was used to determine the protein
concentration of the samples before use in the study.
3.3

Protein Concentration Assay

All protein samples including the total cell lysate protein, exosomes purified using
polymer precipitate, and exosomes purified using fully functionalized probes were
quantified using a Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, Cat. #
23225). The BCA working reagent (WR) was prepared by mixing BCA Reagent A with
BCA Reagent B at a 50:1 ratio respectively at room temperature. The protein standards
(A-I) were prepared using RIPA lysis buffer (TFS, Cat. #89900) mixed with protease
inhibitors (Roche, Cat. # 04693124001) as a diluent and stored at -20 °C until further use.
The standard concentrations were prepared according to the protocol, using RIPA as the
diluent.
The standard was prepared using the provided 2000 ng µL-1 bovine serum
albumin (BSA) protein. The first two dilutions were prepared from the stock BSA
solution and RIPA diluent to produce concentrations of 1500 ng µL-1 and 1000 ng µL-1
respectively. The remaining dilutions were prepared serially from the first two dilutions
using RIPA as the diluent to create a standard curve with values of 750 ng µL-1, 500 ng
µL-1, 250 ng µL-1, 125 ng µL-1, 25 ng µL-1, and 0 ng µL-1 (blank, RIPA only). The
standard curve was used to determine the concentration of the protein samples. The
working volume of the samples was reduced to 2 uL from the original protocol to adjust
for the requirements of the NanoDrop™ reader. The WR was mixed at a 1:1 ratio for
each standard and sample measured (3 µL with 3 µL), vortexed, heated at 65 °C for 5
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minutes using a heat block, and the absorbance was measured at 562 nm using a
NanoDrop™ 2000 (Thermo Fisher) spectrophotometer.
3.4

Fluorescent Imaging Analysis

Fully functionalized microprobes were prepared using the protocol described
above. Once functionalized, the probes were incubated in cell media for 16 hours at 4 °C
with agitation on an orbital shaker. For the fluorescent imaging analysis 6 experimental
groups were prepared: CD63, CD63 + 0.1% BSA, Biotin, Biotin + 0.1% BSA, Negative
Control and Negative Control + 0.1% BSA. The CD63 group was functionalized with
anti-CD63 antibodies for exosome capture. The efficiency of BSA as a blocking reagent
was investigated after 20 minutes of incubation in a 0.1% BSA solution following the
antibody immobilization.
Control experiments in this analysis will be performed by using biotin-only
coated probes for comparison with the anti-CD63 fully functionalized microprobes. The
biotin-only probes are expected to have none or a very low level of fluorescence while
the CD63 functionalized probes are expected to produce a uniform signal. The Biotin
only group serves as a control that does not include anti-CD63 antibodies. These control
experiments were included to determine the rate of non-specific exosome adherence to
the biotin-covered surface of the probes in the presence and absence of 0.1% BSA
blocking reagent. Before administering the blocking reagent, 0.1% BSA was also used as
a wash buffer by dipping the probes into the buffer and allowing them to air dry before
continuing to the next step. The negative control groups were included to test the degree
of nonspecific fluorescence signal. For these control experiments, fully functionalized
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probes were incubated with primary and secondary detection antibodies while the cell
media incubation step was omitted.
Following the preparation of all 6 groups, the probes were incubated in a mixture
of CD9 and CD81 primary antibodies (R&D Systems, Cat. #MAB25292, Cat.
#MAB46151) at a concentration of 0.05 µg µL-1, per vendor recommendation, using 1x
phosphate-buffered saline (PBS) as a buffered diluent for 1 hour at room temperature.
The groups were then dipped in a 0.1% BSA solution for a quick wash, allowed to dry,
and incubated in NL557-conjugate fluorescent secondary antibody (R&D Systems, Cat.
#NL007) at a concentration of 0.005 µg µL-1, per the vendor recommendation, for 1 hour
at room temperature in the dark. Another quick wash was performed following the
secondary antibody incubation step, allowing the probes to air dry before imaging. All
probes were imaged using the 557 red filters at a 16% exposure in the EVOS FL
instrument (Thermo Fisher Scientific) with the RFP LED cube. The images were
analyzed using Image J software by manually highlighting the area of the probe
exhibiting fluorescence and measuring, setting the software to include area, integrated
intensity, and mean gray value in the measurement. Following the measurement of the
fluorescence, an area on the probe that did not exhibit fluorescence was highlighted, at
the same size as the fluorescence area, to establish the “blank” fluorescence, keeping the
measurement settings the same in the software. The fluorescence and blank
measurements were moved into excel to calculate the corrected total cell fluorescence
(CTCF) using the formula: Integrated Density – (Area of selected cell * Mean
fluorescence of blank readings). Four images were analyzed for each probe and five
probes were analyzed per treatment group. 1-6 fluorescence measurements were taken
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per image, depending on the coverage of fluorescence on the probe (Appendix A). 3
blank measurements were taken for every fluorescence measurement. The mean value
was calculated for the fluorescence measurements, and the blank measurements before
using the CTCF calculation. Results from the fluorescent probe analysis will be utilized
to assess the specificity of the solid phase microprobe purification technique for exosome
isolation.
3.5

SDS-PAGE

The total protein, exosome polymer reagent, and exosome probe proteins were
allowed to thaw from -20 °C storage to room temperature and were mixed at a 1:1 ratio
with Lameli buffer. The concentration of each protein sample was 2 µg µL-1. All protein
samples were denatured at 90 °C for 8 minutes, allowed to cool back down to room
temperature to avoid melting the gel, and then loaded into a stain-free polyacrylamide gel
(BioRad, Cat. #4561093) for electrophoresis (4-20%) at a concentration of 20 µg per
lane. The SDS buffer was prepared by mixing 10x Tris/Glycine/SDS Buffer (BioRad,
Cat.#1610732) with D.I water at a ratio of 1:10. The gel was loaded into the
electrophoresis chamber with the protein samples alongside a BioRad Kaleidoscope
Protein Standard (Cat. #1610375) on either side of the protein lanes. Electrophoresis was
performed at 90 V for 55 minutes until the samples and the standard reached the end of
the gel. The gel was imaged using a BioRad ChemiDoc Imaging System, after 45 seconds
of exposure to UV light.
3.6

Western Blot Analysis

The expression levels of two different classes of proteins: CD63 (exosomespecific) and Rab5 (endosome-specific) will be measured via Western Blot analysis. The

24
presence of these proteins will be used to exclude the possible presence of membrane
vesicles derived from membrane shedding and disruption (Logazzi et al., 2009). The
presence of canonical exosome proteins (CD63) and endosome-specific Rab5 will
demonstrate a pure exosome preparation (Lobb et al., 2015) that can be used for
comparative proteomic analysis.
The protein samples (total cell lysate and exosomes purified using polymer
precipitation) were thawed from -20 °C storage to room temperature and measured in
concentration using the BCA assay previously described. The total cell lysate sample was
prepared by using 30 uL of RIPA buffer mixed 1:7 with protease inhibitors directly on
the surface of cultured astrocytes. The astrocytes were seeded in a T-75 flask and had
reached confluency when the proteins were extracted (8.4 * 106 cells).
SDS-PAGE was performed before blotting the proteins onto the membrane for
Western blot analysis. SDS-Buffer was prepared by mixing BioRad 10x
Tris/Glycine/SDS Buffer (Cat. #1610732) with D.I water at a ratio of 1:10 according to
the vendor recommendations. All protein samples were loaded into a stain-free
polyacrylamide gel (4-20%, BioRad, Cat. #4561093) at a concentration of 20 µg per well
as follows from left to right: Standard, Exosome, Control, Standard, Exosome, Control,
Standard, Exosome, Control, Empty. Standard refers to BioRad Kaleidoscope Protein
Standard (Cat. #1610375) and was loaded using 5 µL per well. Electrophoresis was run
on the gel at 80 V for 20 minutes. The gel was then equilibrated in transfer buffer for 15
minutes, and the blotting sandwich was then assembled using a standard cassette as
follows: fiber pad, blotting paper, gel, nitrocellulose membrane (BioRad, Cat. #1662807), blotting paper, and fiber pad. The gel was set against the negative electrode, while
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the membrane faced the positive electrode, and a roller was used to remove bubbles in the
blotting sandwich. Transfer buffer was prepared by mixing 200 mL of 10x TrisGlycine
buffer (BioRad, Cat. #1610734) with 400 mL of methanol (VWR, Cat. #BDH1135-1LP)
and 1400 mL of D.I water. Electrophoresis in the transfer buffer was run at 60 V for 1.5
hours with an ice pack in the module to prevent overheating of the gel.
Following the transfer step, Pierce™ western blot signal enhancer (Thermo
Fisher, Cat. #21050) was used according to the vendor recommended protocol. The
membrane was rinsed with D.I. water briefly and incubated in 10 mL of Reagent A at
room temperature for 2 minutes with agitation. The membrane was briefly washed five
times in D.I. water and incubated in Reagent B for 2 minutes at room temperature with
agitation. The membrane was washed five times in D.I. water and the blocking step was
performed.
For the blocking step, the membrane was blocked using a nonfat dry milk blotting
buffer (BioRad, Cat. #1706404) prepared by mixing 3 g of dry milk with 6 mL of 10x
PBS (BioRad, Cat. #1610780) and 54 mL of D.I water. The membrane was blocked for 1
hour at room temperature with agitation using 20 mL of the blocking buffer. The
membrane was cut horizontally with a standard, exosome sample (polymer precipitation),
and control (total cell lysate) sample on each side of the membrane. CD63 and RAB5
primary antibodies (Proteintech®, Cat. #25682-I-AP, Cat. #11947-I-AP) were each
prepared at a 1:500 dilution in the blocking buffer, adding Tween 20 (BioRad, Cat.
#1610781) at 0.1% of the solution. The membranes were incubated in 6 mL of the
primary antibody overnight (14 hours) at 4 °C with agitation. Following the primary
incubation, each membrane was briefly washed in wash buffer and then washed four
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times for 5 minutes each with agitation in 8 mL of wash buffer. The wash buffer was
prepared by mixing 449.5 mL of D.I Water with 50 mL of 10x PBS and 500 uL of 10%
Tween 20. The secondary antibody (Invitrogen, Cat. #31460) was prepared at a 1:10,000
dilution in the blocking buffer with Tween 20 added at a final concentration of 0.2%. The
membranes were incubated in 6 mL of the secondary antibody for 1.5 hours at room
temperature with agitation. Following the secondary incubation, the wash steps were
repeated, and the membranes incubated in SuperSignal™ West Femto chemiluminescent
substrate (Thermo Fisher, Cat. #34094) for 2 minutes, prepared according to the vendor
recommended protocol. Once incubated, the membrane was imaged using BioRad
ChemiDoc Imaging System after 60 seconds of UV exposure and the image was
overlayed with a colorimetric image of the standard.

CHAPTER 4
RESULTS
The ExoSense microprobe capture technology is based on an antigen-specific
interaction with CD63, a tetraspanin surface protein that is unique to exosomes. Because
CD63 is a confirmed surface marker for exosomes (Mathieu et al., 2019), it is
hypothesized that the probes are capable of selectively isolating exosomes from
biological samples. High selectivity of exosome capture has already been observed with
the use of antigen-specific Dynabeads™ (Doyle and Wang 2019), however, the high-salt
buffer required for removing the vesicles from the beads destroys the recovered sample.
Our technology reduces the procedure for exosome capture down to a single step,
offering the ability to analyze exosome contents directly from the probes without
introducing salt contaminants or other potentially destructive procedural steps. The main
objective of these experiments was to compare the exosomal contents of a probe-captured
sample with a traditional polymer precipitation method of exosome isolation using SDSPAGE and to characterize the exosomes on the surface of the probes using fluorescent
imaging analysis to validate our hypothesis concerning exosome-directed CD63
enrichment on the surface of the ExoSense microprobes.
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4.1

SDS-PAGE

The lanes of the gel depict the following groups from left to right: Std., exosome
probe sample, exosome polymer reagent sample, and Std, with Std. indicating the Biorad
Kalidescope™ protein standard. (Figure 4.1). A 45 second exposure time was used to
optimally show the protein bands for each sample. A gel image with a 10-second
exposure was merged with the 45 second image to more accurately identify the molecular
weights of each band. Protein bands in the 20-25 kDa range were detected in all three
experimental groups. Bands with a molecular weight of around 65 kDa were observed in
the probe samples only. A protein band around the 72 kD marker was not visible within
the probe protein sample and is faintly visible within the polymer reagent and total
protein groups. Overall, the SDS-PAGE results depict fewer bands in the probe sample
when compared to the polymer reagent and total protein groups.
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Figure 4.1: Comparison of exosome isolation methods via SDS-PAGE analysis.
BioRad Kalediscope™ protein standard was loaded to the left and right of the protein
samples as a clearly defined molecular weight scale, and the protein sizes are indicated
at the right of the figure (kD). From left to right following the standard, the protein
samples were loaded as: exosomes captured using probes, exosomes purified using the
polymer precipitation reagent, and the total cell lysate. All protein samples were
prepared at a 1:1 ratio with Lameli buffer and loaded at a concentration of 20 µg per
well.
4.2

Fluorescent Imaging

The fluorescent analysis resulted in 6 clearly defined groups (Figure 4.2). The
CD63 group expressed the most fluorescence of all of the groups and shows a significant
difference when compared to the Biotin and Negative Control groups. Fluorescence was
detected in the Biotin groups, indicating a certain level of non-specific binding of
exosomes to the probes. Finally, the Negative Control groups indicate a negligible
amount of fluorescence detected, likely contributed by the non-specific binding of the
fluorescent antibodies to the probes. Each group can be accurately assessed to predict and
validate the specificity of exosome capture by the probes.
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**

***

Figure 4.2: Corrected Total Cell Fluorescence (CTCF) of functionalized microprobes
for specificity analysis. 6 groups of probes (CD63, CD63 + 0.1% BSA, Biotin, Biotin +
0.1% BSA, Negative Control, Negative Control + 0.1% BSA) were immobilized with
anti-CD9 primary antibodies and secondary 557 nm fluorescent antibodies and imaged
using an EVOS fluorescent imaging machine with RFP LED cube, 16% exposure
saturation. Images were analyzed using Image J and calculated in excel with the CTCF
formula. P-values resulting from Wilcoxon Rank Sum (Mann Whitney-U test for
distributions of unequal variance).
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4.3

Western Blot

Protein samples from polmer precipitated exosomes, BioRad protein standard,
and total cell protein were loaded into a polyacrylamide gel and transfered to a
nitrocellulose membrane. The membrane was then cut in half vertically with one half
prepared with CD63 and the other half with RAB5 primary antibodies according to the
previously described protocol. Both membranes were imaged using 60 seconds of
chemiluminescent exposure and merged with a colorimetric image to visualize the bands
of the standard. The groups appear on the membranes (placed side by side for imaging) as
follows on the CD63 side: exosome sample, total cell control protein, and on the RAB5
side: protein standard, exosome sample, total cell control protein. No clear bands are
visible in the control proteins (Figure 4.3). One faint band is visible in each membrane of
the polymer precipitated exosome samples, at 23 kDa and 24 kDa respectively. These are
the expected molecular weights described by the primary antibodies each membrane was
incubated in, suggesting the presence of CD63 and RAB5 antigen enrichment in the
samples. A thick band is present at the 150 kDa mark and can be indicative of nonspecific binding by the primary antibodies.

32

Figure 4.3: CD63 and RAB5 Western blot membrane. Nitrocellulose membrane loaded
with 20 µg per lane and cut in half lengthwise following blocking step. Primary
incubation in CD63 and RAB5, 1:500 dilution in blocking buffer. Secondary incubation
1:10,000. Faint bands appear on each membrane at the 20-25 kDa range, indicating both
CD63 and RAB5 positive antigens in the exosome (polymer precipitation) sample.

CHAPTER 5
DISCUSSION
5.1

SDS-PAGE protein profile

SDS-PAGE separation was performed to assess the protein bands profile of
exosomes purified via traditional polymer precipitation, exosomes enriched with the
ExoSense microprobe, and total protein from cell lysate. The gel image depicts fewer
bands in the probe-derived sample when compared to the polymer-precipitated and total
protein groups (Figure 4.1). The total cell lysate is expected to be composed of a larger
variety of proteins when compared to the exosomal samples. The presence of more and
thicker bands in the polymer-precipitated exosomal sample compared to the ExoSense
probe is probably due to co-precipitation of non-exosomal proteins, which is a commonly
reported issue. The probe-derived exosomal sample displayed three distinct protein bands
of approximately 50 kDa, 60 kDa, and 250 kDa. The protein band in the 20-25 kDa
range in the SDS-PAGE gel image is more pronounced in the total cell lysate sample
while being faint in the polymer-precipitated sample, and barely visible in the probeisolated protein lysate. Because all protein samples were measured and loaded at the
same concentration (20 µg per lane), the thicker bands reflect the cumulative amount of
similar-sized proteins, which are more heterogeneous in the total cell lysate and more
uniform in the probe-isolates. These bands could be indicative of CD63 or RAB5 proteins
33
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associated with exosomes as they fall into this molecular weight range, however, the
identity of these bands cannot be confirmed with SDS-PAGE alone. The fluorescent
imaging analysis can be used to confirm the enrichment of CD63 proteins from the
probes.
The probe sample gives the appearance of four distinct protein bands as well as
the faded appearance of two additional bands. The highly concentrated protein band at
the 67 kDa mark is most likely bovine serum albumin (BSA), collected in the sample
residually from the 0.1% BSA blocking step of the probe preparation. Although the
identity of the 67 kDa protein band cannot be confirmed from the SDS-PAGE analysis, it
is understandable that BSA from the probes would be lysed by the RIPA buffer alongside
the exosome proteins considering that the BSA-probe bond is relatively weak. The
collection of residual BSA is a relevant factor to consider in the optimization process of
the microprobe protocol for application purposes.
Because all protein samples were measured and loaded at the same concentration
(20 µg per lane), the strength of the bands likely reflects the specificity of proteins
collected in each sample. For instance, previous research indicates that all samples are
expected to have a protein marker in this range (Kowal et al., 2016), but the total protein
sample should contain a larger variety of proteins than the polymer precipitation and
probe samples because exosomes contain fewer proteins than the cell as a whole (Valadi
et al., 2007). The presence of more, stronger bands in the polymer reagent sample
compared to the probe sample is likely indicative of excess proteins or cell lysate
precipitated in the polymer reagent sample along with the exosomes while the fainter,
fewer bands in the probe sample likely reflects higher specificity of proteins collected by
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the probes. This is also supported by the faintly visible band that is present in the polymer
reagent sample around 72 kD, which could indicate the presence of Calnexin, a protein
not present in exosome samples (Matheiu et al., 2019) that likely appeared from excess
proteins collected in the precipitate. This band is not visible in the probe sample, further
supporting the exosome-specificity proteins collected by the probes.
5.2

Specifically defined fluorescence groups

The fluorescent imaging analysis (Figure 4.2) shows distinct differences between
all 6 groups prepared. The CD63 group expressed the most fluorescence because it was
functionalized with the anti-CD63 antibody, enabling the enrichment of exosomes by the
probes and therefore a larger surface area for the CD81 and CD9 fluorescent antibodies to
bind to. The blocking reagent reduced the fluorescent signal for each group, indicating
that the 0.1% BSA solution reduced the presence of non-specifically adhered fluorescent
antibodies on the probes. The negative control groups can be used to subtract the nonspecific signal obtained from the fluorescent antibodies, and the Biotin groups can be
used to subtract the non-specific signal obtained by the probes, yielding a more accurate
estimate for the capture ability of the probes overall. After removing the non-specific
signals detected by all other groups, the CD63 + 0.1% BSA group still exhibits a
significant fluorescent signal, supporting our hypothesis that the ExoSense probes
provide specific and efficient exosome capture.
5.3

Impact of exosomal sample method

The traditional Dynabeads™ immunosolation method for exosome purification
includes an enrichment step to increase the concentration and purity of collected CD63+
exosomes. However, enriching an exosome population from a biological sample typically
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involves precipitating the exosomes using a commercially available enrichment reagent
that increased the cost and duration of the procedure. Our method of using microprobes
allows for the direct capture of exosomes from cell media, potentially providing a pure
exosome population but at a significantly lower concentration than what the enrichment
step yields. Direct exosome isolation from cell media also presents an increased exposure
to excess particulates, potentially interfering with the concentration of pure exosome
populations obtained, as compared to other studies (Dash et al., 2020). The SDS-PAGE
analysis suggests that the exosome population isolated using the microprobes is higher in
purity than the exosomes isolated using the polymer precipitation reagent, as there are
more bands present in this group (Figure 4.1). Excess particulates’ interference can
potentially be accounted for with the use of the blocking step on the microprobes.
However, the concentration of populations isolated will require optimization to account
for the number of microprobes necessary for sufficient exosome extraction.
5.4

The efficiency of BSA blocking

The blocking step (0.1% BSA) was included to evaluate the specificity of each
experimental group. This additional step was included to reduce the possibility of
nonspecific binding by the fluorescent antibodies and captured microvesicles on the
probes. Although the T-test indicates that these 0.1% BSA groups are not statistically
significant, there is still a noteworthy effect exhibited by the treatment groups. For each
treatment group where 0.1% BSA was included, the fluorescent signal was considerably
reduced which points to the presence of nonspecific binding on the probes. A lack of
statistical significance may indicate that the level of nonspecific binding is considerable
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and should be further evaluated during the optimization stage of the microprobes for
standardized commercial use.
5.5

Western blot analysis

The Western blot results are indicative of a protocol that may not be fully
optimized for exosome protein samples. Several factors should be considered in the
optimization process of this protocol that includes exosomal protein and antibodies
concentrations as well as blocking reagents optimization. The exosome protein content is
very low and more homogeneous when compared with a traditional sample. The amount
of protein loaded per lane likely needs to be higher for exosome samples to account for
the lower concentration in the final bands. The higher background noise may be related to
interactions of the specific primary or secondary antibodies with the blocking buffer,
therefore, better signal-to-noise images can be obtained after further adjustments of the
conditions. Bands in the 20-25 kDa range (Figure 4.3) are indicative of CD63 and RAB5
antigens present in the exosome samples and could be used to confirm the identity of
specific proteins from exosome samples upon optimization of the protocol showing a
clearer result.
Western blot results were not obtained from the ExoSense probe collected
exosome samples. The protein samples were lysed directly from the probes, most likely
leaving the surface membrane tetraspanin proteins on the probes’ surface. Only residual
tetraspanins left in the protein sample are not enough to confirm the presence of this
marker from the probe sample via Western blot. It has also not yet been confirmed that
CD63 proteins can be present within exosome samples, therefore, the best method for
confirming the enrichment of CD63 by the ExoSense probes is through fluorescently
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labeled antibody imaging and analysis on the surface of the probes, as indicated in this
study (Figure 4.2).
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CHAPTER 6
CONCLUSIONS AND FUTURE WORK
6.1

Conclusions and future directions

The reduced bands in the probe sample of the SDS-PAGE gel when compared to
the polymer reagent and total protein samples demonstrate the reduced capture of
proteins and therefore support the use of the probes as a more specific method of
exosome capture than the traditional precipitate method. CD63 is confirmed to be an
exosome-specific protein (Matheiu et al., 2019). Therefore, the fluorescent imaging
analysis yielding a significant signal after the removal of non-specific signals indicates an
exosome-specific capture ability of the probes. Together, the SDS-PAGE and fluorescent
imaging analysis results validate the microprobes as a highly specific, efficient method of
exosome capture compared to the traditional capture method.
However, a more specific method means the amount of protein collected has to be
much higher before results can be depicted using traditional proteomic studies. Future
work should focus on the application of the microprobes using more complex biological
samples, such as mouse serum or blood, to evaluate the specificity. The results of this
study yield a significant contribution to the field because they support the use of
microprobes as a highly specific, noninvasive method of exosome capture from
biological samples and carry the potential to accelerate the study of exosomes in
molecular biology research as a whole.
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APPENDIX A : FLOURESCENT PROBE IMAGES
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Exemplary images from each treatment group of the fluorescent probe analysis
(Figure 4.2) are shown.

Figure A1: Fluorescent probe image from CD63 treatment group. Fully functionalized
probe, 400 µm scale.

Figure A2: Flourescent probe image from CD63 + 0.1% BSA group. Fully
functionalized probe plus blocking step, 400 µm scale.

40

42

Figure A3: Fluorescent probe image from Biotin group. Biotin-only functionalization,
400 µm scale.

Figure A4: Fluorescent probe image from Biotin + 0.1% BSA group. Biotin-only
functionalization plus blocking step, 400 µm scale.
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Figure A5: Fluorescent probe image from Negative Control group. Biotin-only
functionalization plus the omission of cell media incubation, 400 µm scale.

Figure A6: Flourescent probe image from Negative Control + 0.1% BSA group. Biotinonly functionalization plus omission of cell media incubation plus blocking step, 400 µm
scale.

APPENDIX B : FLUORESCENT PROBE IMAGE ANALYSIS
PROTOCOL
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A flowchart to describe the Image J analysis protocol used to determine CTCF
(Figure 5) is included below.
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Figure B1: Flowchart for visual Image J analysis protocol. Flourescent and blank
measurements were taken within the Image J software and copied into Excel for
calculations. Multiple values were averaged together and the CTCF calculation was
performed.
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